Abortion proponents who say abortion should be between a woman and her doctor must not be talking about chemical abortions. Giving a woman or girl some pills and sending her home to abort her baby—sometimes alone and without proper follow-up—is hardly healthcare.
Our friends across the border in Oklahoma passed legislation to rein in some of these abuses. It is not surprising the Oklahoma Coalition for Reproductive Justice, a pro-abortion organization, has sued, trying to have the courts overturn the law.
Mifepristone and misoprostol are two drugs used over a three-day period in tandem to cause an abortion. Eight women have died because they were instructed to use the drugs in an unapproved manner. According to testimony by abortion clinic administrators during legislative hearings in 2011, abortion providers in Arkansas routinely ignore FDA protocols for use of these drugs, and there is no law to prevent this.
Chemical abortions are the wave of the future—and they’re much more profitable than surgical abortion. Abortion doctors can pass out pills to more patients more quickly than they can do surgical abortions. Never mind the trauma experienced when the woman or girl comes face to face with her own lifeless baby at home alone.
Several years ago, State Health Director Dr. Joycelyn Elders told pro-lifers to “get over their love affair with the fetus.” Maybe it is time the abortion industry got over its love affair with money. But, since that’s not likely to happen any time soon, our Arkansas lawmakers need act. You can read more in the Aug. 22 issue of LifeNews at:
Related posts:
Planned Parenthood Sues State, Says It May End Chemical Abortions Under New Law
AR Pro-Life Law Could Stop Clinics From Doing Chemical Abortions
House Committee Advances Pro-Life Bill Addressing Chemical Abortions
Legislature Passes Bill Clarifying Penalties for Doctors Who Perform Illegal Chemical Abortions